Pharmaceuticals, Biotechnology and Life Sciences
IRVINE, Calif., June 18, 2021 (GLOBE NEWSWIRE) — Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a late clinical-stage biopharmaceutical company whose mission…
All children (100%) treated presymptomatically in the SPR1NT two-copy cohort survived without respiratory or nutritional support, and sat independently for…
NEW YORK, June 18, 2021 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentation of data from the ULTIMATE I…
SOUTH SAN FRANCISCO, Calif., June 18, 2021 (GLOBE NEWSWIRE) — RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused…
– Second New Drug Application (“NDA”) approved for Sulanda in China – – The pivotal Phase III SANET-p trial demonstrated…
Bethesda, Maryland , June 18, 2021 (GLOBE NEWSWIRE) — Evergreen Therapeutics, Inc. (“Evergreen,” or the “Company”), a fast-growing clinical stage…
Scheduled to Reconvene on June 30, 2021Company Urgently Encourages Stockholders to Vote BUENA, N.J., June 18, 2021 (GLOBE NEWSWIRE) —…
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information…
European Commission approves Aubagio® (teriflunomide) as the first oral MS therapy for first-line treatment of children…
Presentation to be part of the “Development of New Front Line Therapies to Prevent and Treat Non-SARS-CoV-2 Endemic Viral Diseases”…